See also this year's filing and all EDGAR filings for this company.
PDF Report 0001386570_2024_Niagen_Bioscience_Inc.pdf
Logs
Graph
Absolute values for 0001386570, Niagen Bioscience Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 2,563,000 |
| 1 | LiabilitiesCurrent | 20,622,000 |
| 2 | remainder_Liabilities | 3,323,000 |
| 3 | AssetsCurrent | 49,534,000 |
| 4 | AssetsNoncurrent | 2,783,000 |
| 5 | PropertyPlantAndEquipmentNet | 2,137,000 |
| 6 | Goodwill | 510,000 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 84,211,000 |
| 9 | ResearchAndDevelopmentExpense | 4,958,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 83,570,000 |
| 12 | remainder_NetIncome | 661,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 26,508,000 |
| 1 | Assets | 54,964,000 |
| 2 | Expenses | 89,169,000 |
| 3 | Revenues | 83,570,000 |
| 4 | StockholdersEquity | 28,456,000 |
| 5 | NetIncome | -4,938,000 |
| 6 | ComprehensiveNetIncome | -4,938,000 |
| 7 | BaseVar | 127,436,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.836 |
| 9 | EconomicCapitalRatio | 1.56 |
Edgar->Model Mapping
Feature Distribution
Change over Time
